What hinders Indian pharma companies from making drugs for rare diseases
Modern healthcare is fundamentally dependent on a constant supply of known and new drugs, making their discovery and manufacture a profitable business. The Indian pharmaceutical industry plays a key role in making drugs available globally at low prices, reflected in its projected revenue of about $130 billion by 2030. However, it largely manufactures generics that…
Read More “What hinders Indian pharma companies from making drugs for rare diseases” »